Form 4: Pediatrix Medical Group Director Michael A. Rucker Reports Acquisition of Restricted Stock

Director Michael A. Rucker reports acquisition of 11,427 shares of Pediatrix Medical Group, Inc. restricted stock as part of an annual equity award.

Summary

• Michael A. Rucker, a director of Pediatrix Medical Group, Inc., filed a Form 4 on May 12, 2025, reporting a transaction that occurred on May 8, 2025.
• Rucker acquired 11,427 shares of common stock through a grant of restricted shares, part of the Issuer's Amended and Restated 2008 Incentive Compensation Plan.
• The shares were granted as an annual equity award and will vest on May 8, 2026.
• Following the transaction, Rucker beneficially owns 69,579 shares of Pediatrix Medical Group, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and does not inherently convey positive or negative sentiment. It simply reports a transaction.

Positives

• The grant of restricted stock to a director aligns their interests with those of the shareholders.
• The vesting period of one year encourages long-term commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the holdings of key personnel.

Stakeholder Impact

• The transaction increases the director's alignment with shareholder interests through equity ownership.
• The vesting schedule encourages the director's long-term commitment to the company's success.

Key Dates

Keywords

Form 4, Pediatrix Medical Group, Director, Rucker, Restricted Stock, Beneficial Ownership, Equity Award